A
Anna M. Oprescu
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 4
Citations - 254
Anna M. Oprescu is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Odds ratio & Placebo-controlled study. The author has an hindex of 3, co-authored 4 publications receiving 148 citations.
Papers
More filters
Journal ArticleDOI
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd,Sharron Spriggs,Julia Alishayev,Gary Winkel,Kristina Gurgov,Chris Kudrich,Anna M. Oprescu,Edwin A. Salsitz +7 more
TL;DR: CBD's potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.
Journal ArticleDOI
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey.
Yury Khelemsky,A. Goldberg,Yasmin L. Hurd,Gary Winkel,Allen Ninh,Lucia Qian,Anna M. Oprescu,Jeffrey Ciccone,Daniel Katz +8 more
TL;DR: Patients generally believe that marijuana could be at least somewhat effective for the management of pain and are willing to use cannabinoid compounds for this indication, if prescribed by a physician.
Journal ArticleDOI
Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.
Sarah Ann R. Anderson,Anna M. Oprescu,Diane P. Calello,Andrew A. Monte,Peter S. Dayan,Yasmin L. Hurd,Alex F. Manini +6 more
TL;DR: In this multisite cohort of US adolescents assessed in the ED, SC exposure was associated with higher odds of neuropsychiatric morbidity than cannabis exposure providing a distinct neurospychiatric profile of acute SC toxicity in adolescents.